← Back to Search

Behavioural Intervention

Flourish Digital Intervention for Suicide Prevention

N/A

Recruiting

Led By Candice L Biernesser, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed at the week 12 follow-up assessment visits.

Awards & highlights

Study Summary

This trial tests a digital intervention to reduce suicide risk among SGM youth who experienced cyberbullying. It assesses feasibility, acceptability, & outcomes.

Who is the study for?

This trial is for English-speaking sexual and gender minority (SGM) youth aged 12-17 who have faced cyberbullying or online discrimination recently and have a history of suicidal thoughts or behaviors. They need access to a phone or device but can't join if they require immediate, intensive care or have intellectual challenges that would limit their use of the digital tool Flourish.Check my eligibility

What is being tested?

The study tests 'Flourish', a text messaging chatbot designed to help SGM youth deal with the aftermath of cyberbullying by improving their problem-solving skills, distress tolerance, and motivation to seek help. The goal is to see if using Flourish is practical and helpful in reducing psychological stress and suicidal thoughts.See study design

What are the potential side effects?

Since Flourish is a digital intervention based on communication with a chatbot, there are no direct medical side effects like those associated with medications. However, discussing sensitive topics could potentially cause emotional discomfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed upon completion of the week 12 study visits

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed upon completion of the week 12 study visits

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed upon completion of the week 12 study visits for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Level of intervention usage

Recruitment rates of eligible participants

Retention rates of eligible participants

Secondary outcome measures

Change in psychological distress from baseline to 4 weeks

Change in severity of suicidal ideation and behavior from baseline to 12 weeks

Change in severity of suicidal ideation and behavior from baseline to 4 weeks

+2 more

Other outcome measures

Change in distress tolerance from baseline to 12 weeks

Change in distress tolerance from baseline to 4 weeks

Change in motivation for help-seeking from baseline to 12 weeks

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: FlourishExperimental Treatment1 Intervention

Participants will be onboarded to Flourish by a research study clinician, following which they will receive a text messaging program for 4 weeks as well as an accompanying resources website.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,723 Previous Clinical Trials

16,343,146 Total Patients Enrolled

American Foundation for Suicide PreventionOTHER

33 Previous Clinical Trials

9,765 Total Patients Enrolled

1 Trials studying Suicidal Thoughts

60 Patients Enrolled for Suicidal Thoughts

Candice L Biernesser, PhDPrincipal InvestigatorUniversity of Pittsburgh

1 Previous Clinical Trials

80 Total Patients Enrolled

Media Library

Flourish (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05724784 — N/A

Suicidal Thoughts Research Study Groups: Flourish

Suicidal Thoughts Clinical Trial 2023: Flourish Highlights & Side Effects. Trial Name: NCT05724784 — N/A

Flourish (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05724784 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research encompass participants who are above the age of 35?

"This trial is seeking patients aged 12 to 17 years old. For context, there are 81 trials open for minors and 201 studies available for adults over the age of 65."

Answered by AI

Are there any openings available in this clinical trial at present?

"Clinicaltrials.gov confirms that this study is not actively seeking participants, as it was last modified on February 9th 2023. Despite the fact that recruitment for this trial has ended, there are still 280 other medical trials currently recruiting individuals."

Answered by AI

What paramount objectives is this research endeavor attempting to achieve?

"The primary metric for this trial is Retention rates of eligible participants, which will be tracked upon recruitment. Additionally, it seeks to measure Change in severity of suicidal ideation and behavior from baseline to 4 weeks using the Columbia Suicide Severity Rating Scale (C-SSRS) as well as both Change in severity of suicidal ideation and behaviour from baseline to 12 weeks with C-SSRS and Change in Suicidal Ideation from Baseline to 4 Weeks via the Suicidal Ideation Questionnaire (SIQ)."

Answered by AI

What kind of individuals are qualified to join in this trial?

"This research is recruiting 10 adolescents between 12 and 17 years old who are experiencing suicidal ideation. Applicants must meet the following requirements: a self-declared gender or sexual minority identity, English fluency, access to technology for participating in the trial's intervention, recent experience with cyberbullying/discrimination as assessed by an appropriate survey tool (e.g., Cybervictimization Subscale of Traditional & Cyber bullying Victimisation & Perpetration Scale), and personal history of suicidal thought or action established through Ask Suicide Screening."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Development and Feasibility Testing of a Suicide Prevention Intervention for Sexual and Gender Minority Youth

Candice Biernesser 2023. "Development and Feasibility Testing of a Suicide Prevention Intervention for Sexual and Gender Minority Youth". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05724784.